Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Abbott Laboratories

Market Cap 158B 139B 128B 120B 224B 14,863B 229B 1,539B 596B 7,332B 592B 579B 25,509B P/E 2026 *
22.8x
P/E 2027 * 19.5x
Enterprise Value 169B 149B 138B 129B 241B 15,969B 246B 1,653B 640B 7,877B 636B 622B 27,406B EV / Sales 2026 *
3.37x
EV / Sales 2027 * 3.04x
Free-Float
86.73%
Yield 2026 *
2.81%
Yield 2027 * 3%
1 day+7.63%
1 month+1.93%
3 months-24.71%
6 months-30.19%
Current year-30.19%
1 month 74.08
Extreme 74.08
74.44
Current year 72.68
Extreme 72.68
98.39
1 year 72.68
Extreme 72.68
98.39
3 years 72.68
Extreme 72.68
110.91
5 years 72.68
Extreme 72.68
110.91
10 years 72.68
Extreme 72.68
110.91
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
+7.63%0.00% - - 158B
-0.62%+2.55%-6.91%-7.90% 103B
-0.51%-2.64%+54.91%+56.80% 54.84B
+1.20%+2.66%-3.28%+51.51% 54.69B
+2.68%+4.35%-13.87%-42.39% 39.66B
+2.12%-1.02% - - 29.85B
+1.20%-2.08%-20.35%-44.03% 26.59B
+1.20%+5.20%+52.87%-6.75% 23.77B
-0.46%-1.62%-18.36%-4.42% 20.03B
+1.95%+3.90%-13.53%-2.28% 19.8B
Average +1.57%-2.50%+3.93%+0.07% 41.38B
Weighted average by Cap. +2.70%-2.21%+4.81%+5.75%

Financials

2026 *2027 *
Net sales 50.29B 44.27B 40.84B 38.19B 71.56B 4,740B 72.9B 491B 190B 2,338B 189B 185B 8,135B 54.79B 48.24B 44.5B 41.62B 77.97B 5,165B 79.43B 535B 207B 2,548B 206B 201B 8,864B
Net income 7.02B 6.18B 5.7B 5.33B 9.99B 662B 10.17B 68.5B 26.53B 326B 26.35B 25.78B 1,135B 8.39B 7.39B 6.82B 6.37B 11.94B 791B 12.17B 81.9B 31.72B 390B 31.51B 30.83B 1,358B
Net Debt 11.73B 10.32B 9.52B 8.91B 16.69B 1,105B 17B 114B 44.33B 545B 44.03B 43.07B 1,897B 8.88B 7.82B 7.21B 6.75B 12.64B 837B 12.88B 86.69B 33.58B 413B 33.35B 32.63B 1,437B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
90.53USD
Average target price
116.54USD
Spread / Average Target
+28.73%

Quarterly revenue - Rate of surprise